These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 475933

  • 21. [The haemodynamic effects of dobutamine and dopamine in patients with coronary artery disease. A study performed under general anaesthesia (author's transl)].
    Hess W, Brückner JB, von Faber du Faur J, Schmidt D, Tarnow J.
    Anaesthesist; 1979 Jul; 28(7):316-21. PubMed ID: 314760
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Dobutamine and dopamine after cardiac surgery: greater augmentation of myocardial blood flow with dobutamine.
    Fowler MB, Alderman EL, Oesterle SN, Derby G, Daughters GT, Stinson EB, Ingels NB, Mitchell RS, Miller DC.
    Circulation; 1984 Sep; 70(3 Pt 2):I103-11. PubMed ID: 6744557
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Is calcium a coronary vasoconstrictor in vivo?
    Crystal GJ, Zhou X, Salem MR.
    Anesthesiology; 1998 Mar; 88(3):735-43. PubMed ID: 9523818
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of dobutamine and sulmazol (AR-L115 BS) on myocardial metabolism and coronary, femoral, and renal blood flows: a comparative study in normal dogs and in dogs with chronic volume overload.
    Pouleur H, Marechal G, Balasim H, Van Mechelen H, Ries A, Rousseau MF, Charlier AA.
    J Cardiovasc Pharmacol; 1983 Mar; 5(5):861-7. PubMed ID: 6195477
    [Abstract] [Full Text] [Related]

  • 31. Dobutamine infusion in conscious dogs with and without autonomic nervous system inhibition: effects on systemic hemodynamics, regional blood flows and cardiac metabolism.
    Liang CS, Hood WB.
    J Pharmacol Exp Ther; 1979 Dec; 211(3):698-705. PubMed ID: 512933
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Dopamine may preserve the myocardial oxygen balance better than dobutamine when administered with milrinone.
    Takamatsu I, Karasawa F, Okuda T.
    Can J Anaesth; 2002 Nov; 49(9):968-72. PubMed ID: 12419727
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine.
    Goldberg LI, Hsieh YY, Resnekov L.
    Prog Cardiovasc Dis; 1977 Nov; 19(4):327-40. PubMed ID: 12536
    [No Abstract] [Full Text] [Related]

  • 39. Effects of low-dose dobutamine on coronary hemodynamics, myocardial metabolism, and anginal threshold in patients with coronary artery disease.
    Pacold I, Kleinman B, Gunnar R, Loeb HS.
    Circulation; 1983 Nov; 68(5):1044-50. PubMed ID: 6616788
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.